Clinical and CPET Parameters That Predict Improvement in Functional Capacity After TAVI
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Hospital Clinic of Barcelona
- Trial code
- NCT06833762
- Record updated
- 2 September 2026
- Original description
Determining Clinical and Cardiopulmonary exercise testing Parameters that may predict Improvement in Capacity After Transcatheter Aortic Valve ImplantationRead full original descriptionShow less
Determining Clinical and Cardiopulmonary Exercise Testing Parameters That Predict Improvement in Functional Capacity and Complications After Transcatheter Aortic Valve Implantation
Determining Clinical and Cardiopulmonary exercise testing Parameters that may predict Improvement in Capacity After Transcatheter Aortic Valve Implantation
Inclusion: All those patients ≥ 18 years of age with severe aortic stenosis approved for transfemoral TAVI; Both sexes, male and female will be included in the study.
Exclusion: Previous syncope; Previously known dynamic left ventricular outflow tract (LVOT) obstruction, defined as LVOT gradient of ≥ 30 mmHg by echocardiography; Concomitant coronary artery disease pending percutaneous coronary intervention; Proven exercise-induced arrhythmias; Very severe aortic stenosis, defined as a valve area of ≤0.6 cm2; , mean gradient ≥60 mmHg or Vmax >5 m/s; Inability to consent; Physical limitation to perform an exercise test; Non-elective procedure; Valve-in-valve procedure.